The Global Epstein - Barr virus Monovaccine Market is estimated to be valued at US$ 12.01 Tn in 2024 and is expected to exhibit a CAGR of -10% over the forecast period from 2024 to 2031. https://www.newswirestats.com/monovaccine-epstein-barr-virus-market-forecasts-and-trends-analysis/